SC 13G/A

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Company: Galmed Pharmaceuticals Ltd.
Filed: February 14, 2020
Accession Number: 0000921895-20-000543

View Document ↗ View on SEC.gov ↗